DICLOFENAC SODIUM, DIFLUNISAL AND NAPROXEN: PATIENT PREFERENCES FOR ANTI-INFLAMMATORY DRUGS IN RHEUMATOID ARTHRITIS
E. C. Huskisson, Paul Dieppe, J. T. Scott, H Jones
Abstract
E. C. Huskisson, Paul Dieppe, J. T. Scott, H Jones
Abstract
Ninety patients with active rheumatoid arthritis took part in a cross-over trial comparing diclofenac sodium, diflunisal and naproxen. The efficacy of the three drugs was similar though there were trends in favour of diclofenac sodium in some measurements. The incidence of side-effects was similar with the three drugs and each was chosen by a significant group of patients as continuation therapy at the end of the study.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ninety patients with active rheumatoid arthritis took part in a cross-over trial comparing diclofenac sodium, diflunisal and naproxen. The efficacy of the three drugs was similar though there were trends in favour of diclofenac sodium in some measurements. The incidence of side-effects was similar with the three drugs and each was chosen by a significant group of patients as continuation therapy at the end of the study.
Key concepts: Diflunisal, Medicine, Naproxen, Diclofenac Sodium, Rheumatoid arthritis, Diclofenac, Naproxen Sodium, Incidence (geometry)